Nocturia and antidiuretic pharmacotherapy

Nocturia: Causes, Consequences and Clinical Approaches

Volumn , Issue , 2012, Pages 135-146

  Van Kerrebroeck, Philip E V ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antidiuretic Pharmacotherapy; Arginine vasopressin (AVP); Desmopressin; Hyponatremia; Nocturia; Overactive Bladder (OAB); The Noctopus trials

Indexed keywords

EID: 84876416692     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1156-7_9     Document Type: Chapter

References (46)

1. Van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:179.
2. Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;57:488.
3. Fiske J, Scarpero HM, Xue X, Nitti VW. Degree of bother caused by nocturia in women. Neurourol Urodyn. 2004;23:130.
4. Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol. 1995;153:669.
5. van Dijk MM, Wijkstra H, Debruyne FM, de la Rosette JJ, Michel MC. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2009;104:143.
6. Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2008;10:540.
7. Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int. 2006;98:599.
8. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC Study. Eur Urol. 2006;50:1306.
9. Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol. 2010;184:440.
10. Ancoli-Israel S, Bliwise D, Norgaard J. The effect of nocturia on sleep. Sleep Med Rev. 2010;36:254.
11. Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184:1413.
12. Weiss JP, Weinberg AC, Blaivas JG. New aspects of the classification of nocturia. Curr Urol Rep. 2008;9:362.
13. Chang SC, Lin AT, Chen KK, Chang LS. Multifactorial nature of male nocturia. Urology. 2006;67:541.
14. Brubaker L, FitzGerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:737.
15. Koseoglu HO, Aslan G, Ozdemir I, Esen A. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology. 2006;67:1188.
16. Schneider T, de la Rosette JJ, Michel MC. Nocturia: a non-specific but important symptom of urological disease. Int J Urol. 2009;16:249.
17. Klingler HC, Heidler H, Madersbacher H, Primus G. Nocturia: an Austrian study on the multifactorial etiology of this symptom. Neurourol Urodyn. 2009;28:427.
18. Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, et al. Nocturia and benign prostatic hyperplasia. Urology. 2003;61:786.
19. Kujubu DA, Aboseif SR. An overview of nocturia and the syndrome of nocturnal polyuria in the elderly. Nat Clin Pract Nephrol. 2008;4:426.
20. Abrams P, Mattiasson A, Van Kerrebroeck P, Robertson G. Is nocturnal polyuria a key factor in nocturia? Neurourol Urodyn. 2004;23:466.
21. van Kerrebroeck PE, Rezapour M, Cortesse A, Thuroff J, Riis A, Nprgaard JP. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol. 2007;52:221.
22. Andersson K, Chapple C, Cardozo L, Cruz F, Hashim H, Michel M. Pharmacological treatment of urinary incontinence. Report from the fourth international continence on incontinence. Health Publications Ltd; 2009.
23. Rittig S, Jensen AR, Jensen KT, Pedersen EB. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. Clin Endocrinol. 1998;48:235.
24. Vande Walle JG, Bogaert GA, Mattsson S, et al. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int. 2006;97:603.
25. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985;103:228.
26. Brink HS, Derkx FH, Boomsma F, et al. Effects of DDAVP on renal hemodynamics and renin secretion in subjects with essential hypertension. Clin Nephrol. 1994;42:95-101.
27. Robertson GL, Norgaard JP. Renal regulation of urine volume: potential implications for nocturia. BJU Int. 2002;90:7-10.
28. Suchowersky O, Furtado S, Rohs G. Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson’s disease. Mov Disord. 1995;10:337.
29. Mansson W, Sundin T, Gullberg B. Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. A double-blind study. Scand J Urol Nephrol. 1980;14:139.
30. Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1983;46:854.
31. Kinn AC, Larsson PO. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol. 1990;24:109.
32. Valiquette G, Herbert J, Maede-D’Alisera P. Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol. 1996;53:1270.
33. Fredrikson S. Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand. 1996;94:31.
34. Hilton P, Stanton SL. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol. 1982;54:252.
35. Andersson KE, Appell R, Cardozo L, et al. Pharmacological treatment of urinary incontinence. Plymouth, UK: Plymbridge Distributors Ltd.; 2005.
36. Yoong HF, Sundaram MB, Aida Z. Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia. Med J Malaysia. 2005;60:294.
37. Johnson TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;178:2045.
38. Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006;67:731.
39. Weiss JP, Snyder J, Ellison W, Belkoff L. Klein. Fast-dissolving desmopressin (Melt) is well tolerated in nocturia: results of a randomized, placebo-controlled study. J Urol. 2010;183:e589.
40. Weiss J, Zinner N, Daneshgari F, Klein B, Norgaard J, Ancoli-Israel S. Desmopressin orally disintegrating tablet effectively reduces symptoms of nocturia and prolongs undisturbed sleep in patients with nocturia: results of a randomized placebo-controlled study. International Continence Society; 2010.
41. Yu HJ, Chen FY, Huang PC, Chen TH, Chie WC, Liu CY. Impact of nocturia on symptom- specific quality of life among community-dwelling adults aged 40 years and older. Urology. 2006;67:713.
42. Hernandez FC, Ristol PJ, Estivill E, Batista Miranda JE, Lopez Aramburu MA. Importance of nocturia and its impact on quality of sleep and quality of life in patient with benign prostatic hyperplasia. Actas Urol Esp. 2007;31:262.
43. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks. Eur Urol Suppl. 2005;3:24.
44. Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int. 2002;89:855.
45. Lose G, Lalos O, Freeman RM, van Kerrebroeck P. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol. 2003;189:1106.
46. Lose G, Mattiasson A, Walter S, et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol. 2004;172:1021.